Stablix Therapeutics’ $63 Million Series A Financing

Wilson Sonsini Goodrich & Rosati advised Versant Ventures and NEA on the deal.Stablix Therapeutics announced a $63 million Series A financing. The funding round was led…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now